lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy. This evidence concerns the gene CDKN2B-AS1 and familial pancreatic carcinoma.